Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator.
OA22300AActive Publication Date: 2026-08-31VERTEX PHARMACEUTICALS INC
0 Cites 0 Cited by
Patent Information
- Application Number
- OA1202400363
- Authority / Receiving Office
- OA · OA
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2023-04-05
- Publication Date
- 2026-08-31
- Estimated Expiration
- 2043-04-05
Abstract
This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of CFTR mediated diseases, including cystic fibrosis, using such modulators and pharmaceutical compositions, combination pharmaceutical compositions and combination thérapies employing those modulators, and processes and intermediates for making such modulators.
Need to check novelty before this filing date? Find Prior Art